The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback